Literature DB >> 20128024

Significance and relationship between Cripto-1 and p-STAT3 expression in gastric cancer and precancerous lesions.

Jian-Guo Zhang1, Jing Zhao, Yan Xin.   

Abstract

AIM: To explore the relationship between Cripto-1 (CR-1) and tyrosine phosphorylation STAT3 (p-STAT3) expressions in gastric cancer (GC) and gastric carcinogensis and metastasis.
METHODS: The PV9000 immunohistochemical method was used to detect the expression of CR-1 and p-STAT3 in 178 cases of GC, 95 matched normal gastric mucosa, 40 chronic atrophic gastritis (CAG), 48 intestinal metaplasia (IM) and 25 dysplasia (DYS).
RESULTS: The positive rates of CR-1 and p-STAT3 expression were significantly higher in CAG (65.0% and 60.0%), in IM (83.3% and 77.1%), DYS (80.0% and 68%) and GC (71.3% and 60.1%) than in normal gastric mucosa (43.2% and 41.1%, P < 0.05), respectively. The expressions of CR-1 and p-STAT3 (78.3% and 66.7%) were significantly higher in GC with lymph node metastasis than in those without metastasis (53.1% and 42.9%, P < 0.05). CR-1 expression was also related to histological and Lauren's types of GC (P < 0.001). Furthermore, there was positive relationship between CR-1 and p-STAT3 expressions in GC (r(k) = 0.189, P = 0.002).
CONCLUSION: The up-regulation of CR-1 and p-STAT3 may play important roles in gastric carcinogenesis and lymph node metastasis. CR-1 and p-STAT3 expression in GC was positively correlated, and the relevant molecular mechanism requires further investigations.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20128024      PMCID: PMC2816268          DOI: 10.3748/wjg.v16.i5.571

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  25 in total

1.  Cripto-1 indirectly stimulates the tyrosine phosphorylation of erb B-4 through a novel receptor.

Authors:  C Bianco; S Kannan; M De Santis; M Seno; C K Tang; I Martinez-Lacaci; N Kim; B Wallace-Jones; M E Lippman; A D Ebert; C Wechselberger; D S Salomon
Journal:  J Biol Chem       Date:  1999-03-26       Impact factor: 5.157

2.  A Nodal- and ALK4-independent signaling pathway activated by Cripto-1 through Glypican-1 and c-Src.

Authors:  Caterina Bianco; Luigi Strizzi; Aasia Rehman; Nicola Normanno; Christian Wechselberger; Youping Sun; Nadia Khan; Morihisa Hirota; Heather Adkins; Kevin Williams; Richard U Margolis; Michele Sanicola; David S Salomon
Journal:  Cancer Res       Date:  2003-03-15       Impact factor: 12.701

Review 3.  Stats: transcriptional control and biological impact.

Authors:  David E Levy; J E Darnell
Journal:  Nat Rev Mol Cell Biol       Date:  2002-09       Impact factor: 94.444

Review 4.  JAK-STAT pathway in carcinogenesis: is it relevant to cholangiocarcinoma progression?

Authors:  Olga V Smirnova; Tatiana Yu Ostroukhova; Roman L Bogorad
Journal:  World J Gastroenterol       Date:  2007-12-28       Impact factor: 5.742

Review 5.  STATs in oncogenesis.

Authors:  T Bowman; R Garcia; J Turkson; R Jove
Journal:  Oncogene       Date:  2000-05-15       Impact factor: 9.867

6.  GRP78 and Cripto form a complex at the cell surface and collaborate to inhibit transforming growth factor beta signaling and enhance cell growth.

Authors:  Gidi Shani; Wolfgang H Fischer; Nicholas J Justice; Jonathan A Kelber; Wylie Vale; Peter C Gray
Journal:  Mol Cell Biol       Date:  2007-11-08       Impact factor: 4.272

Review 7.  Role of STATs as downstream signal transducers in Src family kinase-mediated tumorigenesis.

Authors:  Corinne M Silva
Journal:  Oncogene       Date:  2004-10-18       Impact factor: 9.867

8.  Cripto: a novel target for antibody-based cancer immunotherapy.

Authors:  Pei Xiang Xing; Xiu Feng Hu; Geoffrey A Pietersz; Howard L Hosick; Ian F C McKenzie
Journal:  Cancer Res       Date:  2004-06-01       Impact factor: 12.701

9.  Positive association of up-regulated Cripto-1 and down-regulated E-cadherin with tumour progression and poor prognosis in gastric cancer.

Authors:  X-Y Zhong; L-H Zhang; S-Q Jia; T Shi; Z-J Niu; H Du; G-G Zhang; Y Hu; A-P Lu; J-Y Li; J-F Ji
Journal:  Histopathology       Date:  2008-02-28       Impact factor: 5.087

10.  Molecular characterization of a gene of the 'EGF family' expressed in undifferentiated human NTERA2 teratocarcinoma cells.

Authors:  A Ciccodicola; R Dono; S Obici; A Simeone; M Zollo; M G Persico
Journal:  EMBO J       Date:  1989-07       Impact factor: 11.598

View more
  13 in total

Review 1.  ErbB/EGF signaling and EMT in mammary development and breast cancer.

Authors:  Katharine M Hardy; Brian W Booth; Mary J C Hendrix; David S Salomon; Luigi Strizzi
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-04-06       Impact factor: 2.673

2.  Biological and Clinicopathological Significance of Cripto-1 Expression in the Progression of Human ESCC.

Authors:  Reihaneh Alsadat Mahmoudian; Mohammad Reza Abbaszadegan; Mohammad Mahdi Forghanifard; Meysam Moghbeli; Faezeh Moghbeli; Jamshidkhan Chamani; Mehran Gholamin
Journal:  Rep Biochem Mol Biol       Date:  2017-04

3.  Expression of p-STAT3 and vascular endothelial growth factor in MNNG-induced precancerous lesions and gastric tumors in rats.

Authors:  Xiao-Yan Wang; Lou-Lei Wang; Xuan Zheng; Li-Na Meng; Bin Lyu; Hai-Feng Jin
Journal:  World J Gastrointest Oncol       Date:  2016-03-15

4.  Differentially localized survivin and STAT3 as markers of gastric cancer progression: Association with Helicobacter pylori.

Authors:  Arvind Pandey; Satyendra Chandra Tripathi; Shirish Shukla; Sutapa Mahata; Kanchan Vishnoi; Sri Prakash Misra; Vatsala Misra; Sankar Mitra; Manisha Dwivedi; Alok C Bharti
Journal:  Cancer Rep (Hoboken)       Date:  2018-06-01

5.  Cripto-1 ablation disrupts alveolar development in the mouse mammary gland through a progesterone receptor-mediated pathway.

Authors:  Malgorzata Klauzinska; David McCurdy; Maria Cristina Rangel; Arun Vaidyanath; Nadia P Castro; Michael M Shen; Monica Gonzales; Daniel Bertolette; Caterina Bianco; Robert Callahan; David S Salomon; Ahmed Raafat
Journal:  Am J Pathol       Date:  2015-10-01       Impact factor: 4.307

6.  Establishment and characterization of chemotherapy-enriched sphere-forming cells with stemness phenotypes as a new cell line (BAG50) of gastric carcinoma.

Authors:  Vahid Bagheri; Mehran Gholamin; Atena Mansouri; Mohammad Reza Abbaszadegan
Journal:  Med Oncol       Date:  2022-09-29       Impact factor: 3.738

7.  Elevated expression of Cripto-1 correlates with poor prognosis in non-small cell lung cancer.

Authors:  Chun-Hua Xu; Zhi-Hong Sheng; Hui-Di Hu; Ke-Ke Hao; Qing-Bo Wang; Li-Ke Yu
Journal:  Tumour Biol       Date:  2014-05-29

8.  Stromal cells positively and negatively modulate the growth of cancer cells: stimulation via the PGE2-TNFα-IL-6 pathway and inhibition via secreted GAPDH-E-cadherin interaction.

Authors:  Manabu Kawada; Hiroyuki Inoue; Shun-ichi Ohba; Junjiro Yoshida; Tohru Masuda; Manabu Yamasaki; Ihomi Usami; Shuichi Sakamoto; Hikaru Abe; Takumi Watanabe; Takao Yamori; Masakatsu Shibasaki; Akio Nomoto
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

9.  Cripto Enhances Proliferation and Survival of Mesenchymal Stem Cells by Up-Regulating JAK2/STAT3 Pathway in a GRP78-Dependent Manner.

Authors:  SeungPil Yun; Chul Won Yun; Jun Hee Lee; SangMin Kim; Sang Hun Lee
Journal:  Biomol Ther (Seoul)       Date:  2018-09-01       Impact factor: 4.634

Review 10.  Prognostic Value and Clinicopathological Significance of p-stat3 Among Gastric Carcinoma Patients: A Systematic Review and Meta-Analysis.

Authors:  Kun Ji; Liyan Zhang; Mingxuan Zhang; Qi Chu; Xin Li; Wei Wang
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.